Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 8.32 3.23% 0.26
AXSM closed up 3.23 percent on Thursday, January 17, 2019, on 44 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical AXSM trend table...

Date Alert Name Type % Chg
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 17 Up 4 Days in a Row Strength 0.00%
Jan 16 Calm After Storm Range Contraction 3.23%
Jan 16 Doji - Bearish? Reversal 3.23%
Jan 16 Stochastic Reached Overbought Strength 3.23%
Jan 16 Wide Bands Range Expansion 3.23%
Jan 16 Overbought Stochastic Strength 3.23%
Jan 16 Up 3 Days in a Row Strength 3.23%

Older signals for AXSM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Is AXSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.16
52 Week Low 1.94
Average Volume 2,191,284
200-Day Moving Average 3.3292
50-Day Moving Average 3.8598
20-Day Moving Average 4.8035
10-Day Moving Average 7.262
Average True Range 0.8766
ADX 38.3
+DI 39.0014
-DI 13.7046
Chandelier Exit (Long, 3 ATRs ) 6.5302
Chandelier Exit (Short, 3 ATRs ) 4.5698
Upper Bollinger Band 10.2496
Lower Bollinger Band -0.6426
Percent B (%b) 0.82
BandWidth 226.755491
MACD Line 1.406
MACD Signal Line 0.9863
MACD Histogram 0.4197
Fundamentals Value
Market Cap 196.44 Million
Num Shares 23.6 Million
EPS -1.45
Price-to-Earnings (P/E) Ratio -5.74
Price-to-Sales 0.00
Price-to-Book 5.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.36
Resistance 3 (R3) 9.33 8.96 9.18
Resistance 2 (R2) 8.96 8.70 8.97 9.12
Resistance 1 (R1) 8.64 8.53 8.80 8.67 9.07
Pivot Point 8.27 8.27 8.35 8.28 8.27
Support 1 (S1) 7.95 8.01 8.11 7.98 7.57
Support 2 (S2) 7.58 7.84 7.59 7.52
Support 3 (S3) 7.26 7.58 7.46
Support 4 (S4) 7.29